STEINERT DISEASE
Clinical trials for STEINERT DISEASE explained in plain language.
Never miss a new study
Get alerted when new STEINERT DISEASE trials appear
Sign up with your email to follow new studies for STEINERT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to ease muscle stiffness in rare disease
Disease control OngoingThis phase 3 study tests an experimental drug called AOC 1001 for myotonic dystrophy type 1, a genetic condition that causes muscle weakness and stiffness. About 159 adults who can walk independently are receiving either the drug or a placebo to see if it improves hand function, …
Matched conditions: STEINERT DISEASE
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 06:06 UTC
-
New hope for DM1: Long-Term trial of AOC 1001 begins
Disease control ENROLLING_BY_INVITATIONThis study is for people with myotonic dystrophy type 1 (DM1) who have already taken part in earlier AOC 1001 trials. It aims to see if the drug is safe and works well over a longer period. About 230 adults will receive the medicine by IV and be monitored for side effects and ben…
Matched conditions: STEINERT DISEASE
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC